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TECHNICAL NOTE
INTERVENTIONAL
Porcine Brachial Artery Tortuosity for In Vivo Evaluation of
Neuroendovascular Devices
S. Carniato, M. Mehra, R.M. King, A.K. Wakhloo, and M.J. Gounis
SUMMARY: We report a novel model of arterial tortuosity in the porcine brachial artery for testing of endovascular devices in the ﬂexed
forelimb position. This provides an ideal vascular territory for an in vivo assessment of guidewires, microcatheters, and endovascular
implants because it closely mimics the challenging curvature at the carotid siphon.
ABBREVIATIONS AC average curvature; 3DRA 3D rotational angiography; CCA common carotid artery
Advances in interventional neuroradiology are reshaping thetreatment paradigms and have facilitated the development of
a wide array of endoluminal techniques for vascular lesions that
were earlier only approachable neurosurgically. The ICA siphon is
extremely relevant for intracranial access, because its tortuosity
and bony encasement can be a significant impediment for guide-
wires and microcatheters to gain intracranial access and may also
preclude the delivery of devices like intracranial stents.
As newer devices are developed, they are first evaluated in vitro
and in cadaveric models. Although indispensible, these can only
assess themechanical and structural responses. For a realistic sim-
ulation of the critical vessel viscoelastic andphysiologic responses,
an in vivo assessment of endovascular devices is crucial. We de-
scribe a porcine brachial artery tortuositymodel to provide a chal-
lenging vascular territory for endovascular device testing.
TECHNIQUE
Three Yorkshire swine (male; mean weight, 47 kg) were used for
the purposes of our study. All procedures were conducted in ac-
cordance with the protocol approved by the Institutional Animal
Care and Use Committee of University of Massachusetts Medical
School. The animals were premedicated with glycopyrrolate (0.01
mg/kg). Anesthesia was induced by an intramuscular injection of
tiletamine (Telazol, 5mg/kg), ketamine (2.5mg/kg), and xylazine
(2.5 mg/kg) and maintained with mechanical ventilation of oxy-
gen containing 1%–3% isoflurane. Continuousmonitoring of the
heart rate, respiration, oxygen saturation level (pulse oximetry),
end-tidal carbon dioxide, and temperature allowed real-time as-
sessment of the physiologic status of the animal. A 6F hemostatic
introducer was placed in the right femoral artery by using a mod-
ified Seldinger technique following a cut-down. The introducer
was secured in place, with the distal aspect of the femoral artery
ligated. A 6F catheter was then advanced over the guidewire under
x-ray fluoroscopy.
Animal Positioning
Selective intra-arterial digital subtraction angiography of the right
and left subclavian arteries was performed in both the extended
and the flexed forelimb position of the swine by using table re-
strainers, as illustrated in Fig 1A, -B. The guide catheter was selec-
tively positioned in the brachial branch of the subclavian artery. A
selective intra-arterial injection of the contrast agent (Iopamidol,
Isovue; Bristol Myers Squibb, Princeton, New Jersey) was admin-
istered with a power injector at an injection rate of 2.5 mL/s for
11.2 seconds with a 7-second delay to acquire a 3DRA dataset (Fig
1C, -D).
Image Processing
AC (the parameter used to describe the vessel tortuosity), path
length, and the vessel diameters were determined by using a
method previously described.1 Briefly, the 3DRA dataset was im-
ported to Mimics (Materialize, Leuven, Belgium). The target tis-
sue was extracted from the neighboring tissue through threshold-
ing. To generate a segmentation mask, we set maximum and
minimum threshold values, and the segmentation was further
restricted by cropping the mask. The selected pixels in each sec-
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tion were connected; this step resulted in a clean mask for the use
of 3Dmodel construction. The resulting centerlinewas composed
of control points equally spaced on a constant 0.4-mm interval.
The path length of the extracted centerline and the diameter of the
best-fit circle to the vessel cross-section at each control point were
recorded and averaged.
Statistical Analysis
The AC, path length, and the vessel diameter of the porcine bra-
chial artery vasculature in the flexed and extended position were
compared with a realistic human ICA dataset previously de-
scribed.1 Data normality were tested by using the method de-
scribed by Kolmogorov and Smirnov. Nonparametric data anal-
ysis of the AC and the path length was performed by using the
Kruskal-Wallis test, and a parametric analysis for vascular diam-
eters was performed by using a 2-tailed unpaired t test by using
GraphPad Prism 5.04 software (GraphPad, San Diego,
California).
RESULTS
The AC, path length, and vascular diameter calculated for the
arterial segments (average  standard error of the mean) in the
extended (0.28 0.06 mm1, 13.99 1.66 mm, and 2.60 0.19
mm) and the flexed (0.29  0.02 mm1, 17.59  0.77 mm, and
2.59  0.12 mm) positions in swine are similar (Fig 2). In com-
parison, the values calculated for the population-representative
human carotid siphon are 0.34 0.02 mm1, 22.60 0.79 mm,
and 4.15 0.09 mm, respectively.1
The nonparametric Kruskal-Wallis
test was performed to compare the means
of the AC of the human carotid siphon
and the tortuous bends of the porcine
brachial artery both in the flexed and the
extended position. There was no statisti-
cal difference between the groups (P 
.44). Also, there was no statistical differ-
ence between the path lengths among the
3 groups (P  .45). The vascular diame-
ters between the human and the porcine
arteries were, however, significantly dif-
ferent (P .0001).
The positioning of the forelimb in the
flexed position increased the number of
tortuous bends in comparison with the
extended position (Fig 1, On-line Video)
and emphasized the complexity of the
curvatures. This arterial territory allows a
successful navigation and testing of an ar-
ray of endovascular devices like guide-
wires, microcatheters, endovascular
stents, and delivery systems.
DISCUSSION
Forceful catheterization of the carotid si-
phon can result in thrombosis and vaso-
spasm as a result of endothelial injury.
The growing availability of endovascular
devices for delivery to the intracranial
space creates the need for a more realistic approximation of the
tortuosity of the human intracranial vessels. Themodel described
provides a robust environment to challenge the delivery and de-
ployment of neuroendovascular devices.
Although some physical properties of microcatheters and
guidewires like radio-opacity and handling can be evaluated in in
vitro models, other parameters like steerability/torquability, lu-
bricity, stiffness, and durability are better analyzed in an in vivo
environment. Also, the ability to evaluate the consequences of
endovascularmanipulation like vessel straightening and displace-
ment, vessel vasospasm, endothelial injury, secondary platelet ad-
hesion, fibrin polymerization, and vessel perforation makes in
vivo assessment indispensible.
Models simulating the carotid tortuosity have previously been
described. Some researchers have described complex vascular
surgical maneuvers like encasement of the canine CCA in carotid
siphon replicas.2,3 Also methods for generating tortuosity have
been described by surgical interposition of the Dacron vascular
graft (E.I. du Pont de Nemours and Company, Wilmington, Del-
aware) between the common trunk and the CCA, creating a vas-
cular redundancy, which can be positioned and sutured in place
to create tortuosity simulating the siphon.4 These vascular proce-
dures are considerably challenging technically, requiring a skilled
surgical team and a recovery period before device testing. Animal
models with siphon anatomy resembling humans exist in the
nonhuman primates; however, ethical and financial consider-
ations preclude their use for endovascular device testing.5
FIG 1. Images depicting the positioning of the swine forelimb and the 3DRA acquired through
the guide catheter in the subclavian artery in the extended (A and C ) and the ﬂexed (B and D )
position, revealing their arterial tortuosity (arrows ). The number of bends and the tortuosity of
the path are accentuated in the ﬂexed position.
AJNR Am J Neuroradiol 34:E36–E38 Apr 2013 www.ajnr.org E37
Ourmodel allows a rigorous testing of endovascular devices in
a challenging tortuous vascular environment, in a model that is
easily reproducible and technically much less challenging. Device
performance can be evaluated on the basis of both the qualitative
experience of the device while negotiating the tortuous vascula-
ture and the angiographic response secondary to navigation. The
technique for inducing the tortuosity is very feasible and repro-
ducible and requires no prior surgical preparation. We have suc-
cessfully used this vascular territory to evaluate commercially
available versions of guidewires, microcatheters, endovascular
stents, and their delivery systems. Further validation of the
model was provided by an evaluation of the safety and perfor-
mance profile of final device prototypes, before their incorpo-
ration as commercially available products for clinical use, by
an experienced neuroradiologist.
Although this model is appropriate for an acute assessment,
the tortuous vascular path is positional; repositioning andmanip-
ulating the forelimbmay likely alter the geometry of the endovas-
cular implants over the bends. The caliber of the target vessel does
not replicate the human ICA. The porcine arteries also have a
higher propensity for vasospasm. We cannot replicate the bony
encasement and the level of immobility experienced at the human
carotid siphon. Nevertheless, despite these limitations, endovas-
cular device testing in this territory provides a robust environ-
ment for a rigorous assessment of the delivery and deployment of
endovascular devices in a technically less demanding and repro-
ducible in vivo model.
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FIG 2. Box andwhiskers plots showing themedian, maximum,minimum, and upper and lower quartiles of the average curvature (A), path length
(B), and the vascular diameters (C) of the human carotid siphon and the porcine brachial artery in the ﬂexed and extended position.
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